Literature DB >> 23815669

Lung clearance index and high-resolution computed tomography scores in primary ciliary dyskinesia.

Samantha J Irving1, Andrew Ives, Gwyneth Davies, Jackie Donovan, Anthony J Edey, Simon S Gill, Arjun Nair, Clare Saunders, Nevin T Wijesekera, Eric W F W Alton, David Hansell, Claire Hogg, Jane C Davies, Andrew Bush.   

Abstract

RATIONALE: Lung clearance index (LCI) is a more sensitive measure of lung function than spirometry in cystic fibrosis (CF) and correlates well with abnormalities in high-resolution computed tomography (HRCT) scanning. We hypothesized LCI would be equally sensitive to lung disease in primary ciliary dyskinesia (PCD).
OBJECTIVES: To test the relationships between LCI, spirometry, and HRCT in PCD and to compare them to the established relationships in CF.
METHODS: Cross-sectional study of 127 patients with CF and 33 patients with PCD, all of whom had spirometry and LCI, of which a subset of 21 of each had HRCT performed. HRCT was scored for individual features and these features compared with physiological parameters.
MEASUREMENTS AND MAIN RESULTS: Unlike in CF, and contrary to our hypothesis, there was no correlation between spirometry and LCI in PCD and no correlation between HRCT features and LCI or spirometry in PCD.
CONCLUSIONS: We show for the first time that HRCT, spirometry, and LCI have different relationships in different airway diseases and that LCI does not appear to be a sensitive test of airway disease in advanced PCD. We hypothesize that this results from dissimilarities between the components of large and small airway disease in CF and PCD. These differences may in part lead to the different prognosis in these two neutrophilic airway diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23815669      PMCID: PMC3827705          DOI: 10.1164/rccm.201304-0800OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

Review 1.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

2.  Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia.

Authors:  Nadwa Zihlif; Emmanouil Paraskakis; Christiane Lex; Lauri-Ann Van de Pohl; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2005-06

3.  Longitudinal study of lung function in a cohort of primary ciliary dyskinesia.

Authors:  A Ellerman; H Bisgaard
Journal:  Eur Respir J       Date:  1997-10       Impact factor: 16.671

4.  Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.

Authors:  Andrew Bush; Donald Payne; Sarah Pike; Gavin Jenkins; Markus O Henke; Bruce K Rubin
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

5.  Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.

Authors:  P Aurora; P Gustafsson; A Bush; A Lindblad; C Oliver; C E Wallis; J Stocks
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

6.  Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.

Authors:  Paul Aurora; Andrew Bush; Per Gustafsson; Cara Oliver; Colin Wallis; John Price; John Stroobant; Siobhan Carr; Janet Stocks
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

7.  Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis.

Authors:  P M Gustafsson; P Aurora; A Lindblad
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

8.  Primary ciliary dyskinesia: diagnostic and phenotypic features.

Authors:  Peadar G Noone; Margaret W Leigh; Aruna Sannuti; Susan L Minnix; Johnny L Carson; Milan Hazucha; Maimoona A Zariwala; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2003-12-04       Impact factor: 21.405

9.  Mucociliary clearance in patients with cystic fibrosis and in normal subjects.

Authors:  J A Regnis; M Robinson; D L Bailey; P Cook; P Hooper; H K Chan; I Gonda; G Bautovich; P T Bye
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

10.  Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.

Authors:  Alex R Horsley; Jane C Davies; Robert D Gray; Kenneth A Macleod; Jackie Donovan; Zelena A Aziz; Nicholas J Bell; Margaret Rainer; Shahrul Mt-Isa; Nia Voase; Maria H Dewar; Clare Saunders; James S Gibson; Javier Parra-Leiton; Mia D Larsen; Sarah Jeswiet; Samia Soussi; Yusura Bakar; Mark G Meister; Philippa Tyler; Ann Doherty; David M Hansell; Deborah Ashby; Stephen C Hyde; Deborah R Gill; Andrew P Greening; David J Porteous; J Alastair Innes; A Christopher Boyd; Uta Griesenbach; Steve Cunningham; Eric W F W Alton
Journal:  Thorax       Date:  2013-02-09       Impact factor: 9.139

View more
  26 in total

1.  Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.

Authors:  BreAnna Kinghorn; Sharon McNamara; Alan Genatossio; Erin Sullivan; Molly Siegel; Irma Bauer; Charles Clem; Robin C Johnson; Miriam Davis; Anne Griffiths; William Wheeler; Katherine Johnson; Stephanie D Davis; Margaret W Leigh; Margaret Rosenfeld; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2020-09

2.  Quality of Life Questionnaire for Turkish Patients with Primary Ciliary Dyskinesia.

Authors:  Nagehan Emiralioğlu; Bülent Karadağ; H Uğur Özçelik
Journal:  Turk Thorac J       Date:  2017-01-01

3.  Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.

Authors:  Lauren M Zell-Baran; Silpa D Krefft; Camille M Moore; Jenna Wolff; Richard Meehan; Cecile S Rose
Journal:  Respir Med       Date:  2020-12-05       Impact factor: 3.415

4.  Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients.

Authors:  Michal Gur; Karin Yaacoby-Bianu; Anat Ilivitzki; Ronen Bar-Yoseph; Vered Nir; Fahed Hakim; Yazeed Toukan; Lea Bentur
Journal:  Lung       Date:  2016-08-31       Impact factor: 2.584

5.  Primary Ciliary Dyskinesia: First Health-related Quality-of-Life Measures for Pediatric Patients.

Authors:  Sharon D Dell; Margaret W Leigh; Jane S Lucas; Thomas W Ferkol; Michael R Knowles; Adrianne Alpern; Laura Behan; Anjana M Morris; Claire Hogg; Audrey DunnGalvin; Alexandra L Quittner
Journal:  Ann Am Thorac Soc       Date:  2016-10

6.  Validation of pediatric health-related quality of life instruments for primary ciliary dyskinesia (QOL-PCD).

Authors:  Laura Behan; Margaret W Leigh; Sharon D Dell; Alexandra L Quittner; Claire Hogg; Jane S Lucas
Journal:  Pediatr Pulmonol       Date:  2019-09-01

7.  Imaging Lung Function Abnormalities in Primary Ciliary Dyskinesia Using Hyperpolarized Gas Ventilation MRI.

Authors:  Laurie J Smith; Noreen West; David Hughes; Helen Marshall; Christopher S Johns; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; David J Capener; Jody Bray; Guilhem J Collier; Paul J C Hughes; Graham Norquay; Lynne Schofield; Phil Chetcuti; Eduardo Moya; Jim M Wild
Journal:  Ann Am Thorac Soc       Date:  2018-12

8.  A quality-of-life measure for adults with primary ciliary dyskinesia: QOL-PCD.

Authors:  Jane S Lucas; Laura Behan; Audrey Dunn Galvin; Adrianne Alpern; Anjana M Morris; Mary P Carroll; Michael R Knowles; Margaret W Leigh; Alexandra L Quittner
Journal:  Eur Respir J       Date:  2015-05-14       Impact factor: 16.671

9.  Diagnosis and management of primary ciliary dyskinesia.

Authors:  Claudius Werner; Jörg Große Onnebrink; Heymut Omran
Journal:  Cilia       Date:  2015-01-22

10.  Lung Clearance Index (LCI) is Stable in Most Primary Ciliary Dyskinesia (PCD) Patients Managed in a Specialist Centre: a Pilot Study.

Authors:  S Irving; S Carr; C Hogg; M Loebinger; A Shoemark; A Bush
Journal:  Lung       Date:  2017-06-20       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.